Literature DB >> 10498060

The irritable larynx syndrome.

M Morrison1, L Rammage, A J Emami.   

Abstract

Muscular tension dysphonia, episodic laryngospasm, globus, and cough may be considered to be hyperfunctional laryngeal symptoms. Suggested etiological factors for these symptoms include gastroesophageal reflux, psychological problems, and/or dystonia. We propose a unifying hypothesis that involves neural plastic change to brainstem laryngeal control networks through which each of the above etiologies, plus central nervous system viral illness, can play a role. We suggest that controlling neurons are held in a "spasm-ready" state and that symptoms may be triggered by various stimuli. Inclusion criteria for the irritable larynx syndrome are episodic laryngospasm and/or dysphonia with or without globus or chronic cough; visible or palpable evidence of tension or tenderness in laryngeal muscles; and a definite symptom-triggering stimulus. thirty-nine patients with irritable larynx syndrome were studied. Gastroesophageal reflux was felt or proven to play a major role in a large number of the group (>90%), and about one third were deemed to have psychological causative factors. Viral illness seemed quite prevalent, with one third of patients able to relate the onset of symptoms to a viral illness that we feel might lead to central nervous system changes. Our proposed hypothesis includes a mechanism whereby acquired plastic change to central brainstem nuclei may lead to this form of hyperkinetic laryngeal dysfunction. It gives structure and reason to an array of therapy measures and suggests direction for basic research.

Entities:  

Mesh:

Year:  1999        PMID: 10498060     DOI: 10.1016/s0892-1997(99)80049-6

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  32 in total

Review 1.  Reflux and aerodigestive tract diseases.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Daniela Paccagnella; Robert P Takes; Alessandra Rinaldo; Carl E Silver; Julia A Woolgar; Michael L Hinni; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-07       Impact factor: 2.503

Review 2.  Laryngospasm in neurological diseases.

Authors:  Hans-Jürgen Gdynia; Jan Kassubek; Anne-Dorte Sperfeld
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  [Expiratory vocal cord dysfunction? Case report and review of the literature].

Authors:  M Echternach; T Verse; W Delb; B Richter
Journal:  HNO       Date:  2009-01       Impact factor: 1.284

Review 4.  Upper aerodigestive tract disorders and gastro-oesophageal reflux disease.

Authors:  Andrea Ciorba; Chiara Bianchini; Michele Zuolo; Carlo Vittorio Feo
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

5.  Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.

Authors:  Dhyanesh A Patel; Michael Blanco; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-09

6.  Characteristics of thyroid nodules causing globus symptoms.

Authors:  Inn-Chul Nam; Hoon Choi; Eun-Sook Kim; Eun-Young Mo; Young-Hak Park; Dong-Il Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-31       Impact factor: 2.503

7.  Neurophysiology and Clinical Implications of the Laryngeal Adductor Reflex.

Authors:  Amanda S Domer; Maggie A Kuhn; Peter C Belafsky
Journal:  Curr Otorhinolaryngol Rep       Date:  2013-09

8.  Dyspneic athlete.

Authors:  David Krey; Thomas Best
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

9.  Role of videoendoscopy in phoniatrics: data from three years of daily practice.

Authors:  A Schindler; M Spadola Bisetti; E Favero; R Musto; F Ottaviani; O Schindler
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

10.  Airway Hypersensitivity, Reflux, and Phonation Contribute to Chronic Cough.

Authors:  David O Francis; James C Slaughter; Fehmi Ates; Tina Higginbotham; Kristin L Stevens; C Gaelyn Garrett; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-19       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.